ACT With CF Self-Help Toolkit
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThomas Jefferson University
About this trial
Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying to find out whether a self-help version of this treatment (ACT with CF - Self Help Toolkit) is also effective in reducing anxiety and depression and improving psychological flexibility and value-based living in adults with CF.
Adults with cystic fibrosis are at increased risk for anxiety and depression. This study examines whether a patient-facing therapy, ACT with CF - Self Help Toolkit can help to reduce anxiety and depression among adults with CF. This treatment can be accessed on the participant's smartphone.
Eligibility criteria
Qualifiers
18 years or older
Existing diagnosis of cystic fibrosis
PHQ-9 score >4 or GAD-7 score >4
Disqualifiers
History of suicide attempts or acute suicidal ideation on clinical assessment
Presence of psychotic disorder or symptoms
Presence of psychiatric disorders that interfere with participation in the study, judged by the study or treating clinician
Presence of other medical conditions that interfere with participation in the study, judged by the study or treating clinician
Trial design
Treatments tested in this trial
- ACT with CF Self-Help Toolkit
- Waitlist
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Thomas Jefferson University
Lead sponsor
Boomer Esiason Foundation
Collaborator
Source ClinicalTrials.gov